Kiran Mazumdar-led Biocon Biologics is in the midst of a fund raising blitzkrieg in 2020. It recently sealed a deal with Wall Street powerhouse Goldman Sachs and now it’s in talks for a fourth fund raise.
According to a report by moneycontrol.com, post the Goldman Sachs deal, Biocon Biologics is now in talks with ADQ for a fresh shot of funds.
ADQ is a sovereign wealth fund owned by Abu Dhabi government. ADQ is looking to invest up to 100 million dollars in Biocon Biologics and due diligence is underway.Watch this video for more.